At a Glance
| Gaboxadol | Eszopiclone | |
|---|---|---|
| Class | Hallucinogens, Depressant | Hallucinogens, Depressant, Hypnotic |
| Common Dose (oral) | 15–30 mg | 2–3 mg |
| Total Duration | 1.3–3 hrs | 0.7–1.8 hrs |
| Routes | oral | oral |
Dangerous Combination
Combining Gaboxadol and Eszopiclone is classified as dangerous. Combined CNS depression; risk of respiratory failure
Gaboxadol, a Hallucinogens, Depressant, and Eszopiclone, a Hallucinogens, Depressant, Hypnotic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Gaboxadol is classified as a Hallucinogens, Depressant while Eszopiclone is a Hallucinogens, Depressant, Hypnotic, meaning they approach altered states through different pharmacological mechanisms. They share 8 documented effects in common, with 38 effects unique to Gaboxadol and 18 unique to Eszopiclone. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Gaboxadol | Eszopiclone | |
|---|---|---|
| Class | Hallucinogens, Depressant | Hallucinogens, Depressant, Hypnotic |
| Common Dose (oral) | 15–30 mg | 2–3 mg |
| Total Duration | 1.3–3 hrs | 0.7–1.8 hrs |
| Routes | oral | oral |
| Effects | 46 documented | 26 documented |
| Interaction | Dangerous | |
| Level | Gaboxadol | Eszopiclone |
|---|---|---|
| Threshold | 5 mg | 0.5 mg |
| Light | 10–15 mg | 1–1.5 mg |
| Common | 15–30 mg | 2–3 mg |
| Strong | 30–45 mg | 4–5 mg |
| Heavy | 45 mg | 6 mg |
Gaboxadol
Eszopiclone
Combined CNS depression; risk of respiratory failure